Top 200 Drugs Study

Flashcards, Quiz & Reference

Разработчик: Polemics Applications

Описание

Top 200 Drugs - Flashcards, Quiz & Reference is a comprehensive study companion for healthcare professionals, students, and anyone looking to master the most commonly prescribed medications.
Key Features:
- Flash Card Study with multiple question types and customizable deck sizes
- Dictionary Mode with searchable drug database and Wikipedia integration
- Quiz Mode for testing knowledge with multiple choice questions
- Guided Learning to create custom study sets
- Direct links to Wikipedia articles for in-depth drug information
Study Categories:
- Brand Names and Generic Equivalents
- Primary Uses and Indications
- Drug Categories and Classifications
- Mechanisms of Action
- Side Effects and Patient Counseling
- DEA Schedules and Important Warnings
Perfect For:
- Pharmacy Technicians and Students
- Nursing Students and Professionals
- Medical Professionals
- Healthcare Students
- Board Exam Preparation
Flash Card Study adapts to your learning needs with multiple question types. Choose custom study sessions with 5, 10, 15, or 20 cards, or work through the entire deck. Each card can test your knowledge of brand names, primary uses, mechanisms of action, and more.
Dictionary Mode provides a complete reference list of all 200 drugs with quick search functionality. Each drug entry includes comprehensive information and links directly to Wikipedia articles for deeper learning and detailed pharmaceutical information.
Quiz Mode tests your knowledge through interactive multiple-choice questions with randomized answers. Review missed questions to strengthen weak areas and track your progress with immediate feedback. Our quiz system helps you build confidence through active recall.
Guided Learning lets you create custom study sets focusing on specific medications. Select five or more drugs to study using either flash cards or quiz mode - perfect for mastering challenging medications or preparing for exams.
Features a clean, straightforward interface designed to maximize study efficiency without unnecessary distractions. Whether you're preparing for exams or keeping your knowledge current, this app provides the flexibility and comprehensive coverage you need for success in healthcare.
Скрыть Показать больше...

Скриншоты

Top 200 Drugs Study Частые Вопросы

  • Приложение Top 200 Drugs Study бесплатное?

    Top 200 Drugs Study не является бесплатным (стоимость составляет 8.00), однако оно не содержит встроенных покупок или подписок.

  • Является ли Top 200 Drugs Study фейковым или мошенническим?

    Недостаточно отзывов для надежной оценки. Приложению нужно больше отзывов пользователей.

    Спасибо за ваш голос

  • Сколько стоит Top 200 Drugs Study?

    Цена Top 200 Drugs Study составляет 8.00.

  • Сколько зарабатывает Top 200 Drugs Study?

    Чтобы получить оценку дохода приложения Top 200 Drugs Study и другие данные AppStore, вы можете зарегистрироваться на платформе мобильной аналитики AppTail.

Оценки пользователей
Приложение еще не оценено в Гонконг (САР).
История оценок

Top 200 Drugs Study Отзывы Пользователей

Нет отзывов в Гонконг (САР)
Приложение пока не имеет отзывов в Гонконг (САР).

Оценки

История позиций в топах
История рейтингов пока не доступна
Позиции в категории
Рейтинг
Категория
Позиция
Топ платных
324

Top 200 Drugs Study Установки

30дн.

Top 200 Drugs Study Доход

30дн.

Top 200 Drugs Study Доходы и Загрузки

Получите ценные инсайты о производительности Top 200 Drugs Study с помощью нашей аналитики.
Зарегистрируйтесь сейчас, чтобы получить доступ к статистика загрузок и доходов и многому другому.
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.